Cross Country Healthcare, Inc.
CCRN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 2.94 | 0.15 | -0.37 |
| FCF Yield | 0.53% | 0.79% | 3.70% | 1.43% |
| EV / EBITDA | -320.29 | 91.33 | 492.27 | 45.53 |
| Quality | ||||
| ROIC | -1.48% | -0.11% | -0.70% | 0.45% |
| Gross Margin | 20.43% | 19.99% | 18.60% | 20.36% |
| Cash Conversion Ratio | -4.21 | -0.63 | -11.59 | -6.46 |
| Growth | ||||
| Revenue 3-Year CAGR | -20.38% | -21.10% | -21.89% | -21.76% |
| Free Cash Flow Growth | -40.71% | -82.51% | 241.99% | -92.02% |
| Safety | ||||
| Net Debt / EBITDA | 72.68 | -17.52 | -75.13 | -7.07 |
| Interest Coverage | -10.67 | -1.80 | -5.65 | 5.19 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 51.51 | 72.09 | 68.44 | -17.89 |